Benefits and risks of bisphosphonate therapy for osteoporosis.
Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT.
Khosla S, et al.
J Clin Endocrinol Metab. 2012 Jul;97(7):2272-82. doi: 10.1210/jc.2012-1027. Epub 2012 Apr 20.
J Clin Endocrinol Metab. 2012.
PMID: 22523337
Review.